Infrastructure Capital Advisors, LLC Outlook Therapeutics, Inc. Put Options Transaction History

Infrastructure Capital Advisors, LLC

  • $642 Million
  • Q3 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $326M
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Infrastructure Capital Advisors, LLC Portfolio

Follow Infrastructure Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Infrastructure Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Infrastructure Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email